SANUWAVE Health (SNWV) Free Cash Flow Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | SANUWAVE Health | 137.37 Mn | 126.59 Mn | 7.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.11% |
| Dec 31, 2025 | 25.33% |
| Sep 30, 2025 | 16.35% |
| Jun 30, 2025 | 35.66% |
| Mar 31, 2025 | 10.56% |
| Dec 31, 2024 | 18.01% |
| Sep 30, 2024 | 24.14% |
| Jun 30, 2024 | 18.43% |
| Mar 31, 2024 | 22.46% |
| Dec 31, 2023 | 3.88% |
| Sep 30, 2023 | -24.12% |
| Jun 30, 2023 | -43.43% |
| Mar 31, 2023 | 26.84% |
| Dec 31, 2022 | -44.35% |
| Sep 30, 2022 | -84.57% |
| Jun 30, 2022 | -35.22% |
| Mar 31, 2022 | -93.69% |
| Dec 31, 2021 | 15.08% |
| Sep 30, 2021 | -7.76% |
| Jun 30, 2021 | -23.66% |
| Mar 31, 2021 | -27.77% |
| Dec 31, 2020 | -44.68% |
| Sep 30, 2020 | -30.92% |
| Jun 30, 2020 | -28.86% |
| Mar 31, 2020 | -19.67% |
| Dec 31, 2019 | -9.04% |
| Sep 30, 2019 | 2.20% |
| Jun 30, 2019 | -1.29% |
| Mar 31, 2019 | 9.24% |
| Dec 31, 2018 | -19.89% |
| Sep 30, 2018 | 13.04% |
| Jun 30, 2018 | -15.72% |
| Mar 31, 2018 | -39.21% |
| Dec 31, 2017 | 4.72% |
| Sep 30, 2017 | 18.62% |
| Jun 30, 2017 | 14.71% |
| Mar 31, 2017 | 40.11% |
| Dec 31, 2016 | 23.18% |
| Sep 30, 2016 | 13.39% |
| Jun 30, 2016 | 24.74% |
| Mar 31, 2016 | 12.94% |
| Dec 31, 2015 | 23.12% |
| Sep 30, 2015 | 0.65% |